CD8+ but not CD8- dendritic cells cross-prime cytotoxic T cells in vivo

Journal of Experimental Medicine

Volumn 192, Issue 12, 2000, Pages 1685-1695

  Den Haan, Joke M M ^a   Lehar, Sophie M ^a   Bevan, Michael J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antigen presentation; Antigen presenting cell; Cross priming; Cytotoxic T lymphocyte; Major histocompatibility complex class I

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN; OVALBUMIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; FEMALE; INTRACELLULAR TRANSPORT; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIGENS, CD8; BETA 2-MICROGLOBULIN; CELL DIVISION; DENDRITIC CELLS; ENDOCYTOSIS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSPHERES; MYELOID CELLS; OVALBUMIN; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034684659     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.12.1685     Document Type: Article

References (76)

1. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming
2. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay
3. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
4. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
5. Constitutive class I-restricted exogenous presentation of self antigens in vivo
6. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
7. + T cell responses to infectious agents, tumors, transplants, and vaccines
8. + T cells
9. + T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
10. + T cell help
11. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules
12. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
13. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
14. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells
15. Processing of engulfed apoptotin bodies yields T cell epitopes
16. Presentation of exogenous protien antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines
17. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
18. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells
19. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
20. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells
21. Dendritic cells in the T-cell areas of lymphoid organs
22. Dendritic cells and the control of immunity
23. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells
24. Dendritic cell subtypes in mouse lymphoid organs: Cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes
25. Heterogeneity of mouse spleen dendritic cells: In vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover
26. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse
27. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
28. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen
29. Expression of relB is required for the development of thymic medulla and dendritic cells
30. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage
31. + dendritic cells
32. Distinct signals control the hematopoiesis of lymphoid-related dendritic cells
33. Thymic dendritic cell precursors: Relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny
34. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
35. Myeloid dendritic cells
36. Immunobiology of dendritic cells
37. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production
38. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis
39. - dendritic cells in vivo
40. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
41. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
42. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo
43. T cell receptor antagonist peptides induce positive selection
44. Introduction of soluble protein into the class I pathway of antigen processing and presentation
45. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
46. Degradation of cell proteins and the generation of MHC class I-presented peptides
47. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
48. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
49. The induction of tolerance by dendritic cells that have captured apoptotic cells
50. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo
51. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: Endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue
52. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
53. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
54. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
55. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins
56. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
57. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells
58. + T cells
59. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
60. The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes
61. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
62. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells
63. The evolution of self-tolerance: A new cell arises to meet the challenge of self-reactivity
64. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
65. + T-helper and a T-killer cell
66. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
67. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity
68. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
69. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
70. Role of antigen-presenting cells in mediating tolerance and autoimmunity
71. Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells
72. + lymphoid dendritic cells
73. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo
74. Leukocyte migration: Scent of the T zone
75. + dendritic cells
76. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type I (Th1)-inducing dendritic cells. Absence of CCR2 shirts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines. B cell outgrowth, and sustained neutrophilic inflammation